During a live event, Thomas G. Martin, MD, discussed the importance of controlling disease and avoiding barriers to access so patients with multiple myeloma can receive CAR T-cell therapy.

Researchers discovered that chronic inflammation fundamentally remodels the bone marrow, allowing mutated stem cell clones to ...

A recently published IMPACT-HD (Integrating Proctoscopic Assessment With Patient Experience of Micronized Purified Flavonoid ...

New research suggests that inflammatory support cells play a key role in damaging bone marrow early in cancer development - ...

Researchers have deciphered how chronic inflammation in the bone marrow of patients with age-related blood stem cell ...

Rigel Pharmaceuticals, Inc. posted a solid Q3 with robust sales growth. Discover insights on future profitability and market ...

Home > Press release: New findings on the development of blood ...

Discover why Rigel Pharma (RIGL) is a contrarian biotech BUY with surging revenues, strong drug sales, and 20-30% upside ...

Rocker Doctor AI Inc. (the “ Company ” or “ Rocket Doctor AI ”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) Is pleased to announce, further to its news release of January 28, 2025, that it has entered ...

Luspatercept-aamt (Reblozyl) is among the National Comprehensive Cancer Network (NCCN) guideline recommendations for low-risk ...

Biomarkers such as ring sideroblasts are indicators for response to treatments like luspatercept (Reblozyl). In patients with ...

CURE spoke with Dr. Marina Kremyanskaya about the treatment landscape for patients with polycythemia vera.